跳至主要内容
临床试验/ISRCTN15077843
ISRCTN15077843已完成未知

A randomized, double-blind study to evaluate the efficacy of intra-articular injection of methylprednisolone versus triamcinolone hexacetonide in patients with knee osteoarthritis

Hospital Heliópolis (Brazil)0 个研究点目标入组 100 人开始时间: 2013年9月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Diagnosis of knee osteoarthritis (OA) according to the American College of Rheumatology criteria
  • 2. Kellgren-Lawrence radiographic grade II or III of the knee
  • 3. Visual analogue scale (VAS) for knee pain of at least 40mm (maximum 100mm)
  • 4. Both genders, aged 40 years or older
  • 5. Failure to control OA symptoms with previous or current analgesics and/ or non steroidal antiinflammatory drugs

排除标准

  • 1. Other rheumatic or inflammatory condition
  • 2. Symptomatic disease of the lower limbs (other than knee OA)
  • 3. Serious and/or uncontrolled concomitant medical illness
  • 4. Body mass index (BMI) greater or equal to 35kg/m2
  • 5. IA injection of corticosteroid or hyaluronic acid in the previous 6 months
  • 6. knee replacement in the targeted joint
  • 7. Local or systemic infection
  • 8. Pregnancy
  • 9. Skin lesions in the IA injection site
  • 10. Physical therapy for the knee
  • 11. Known hypersensitivity to corticosteroids or lidocaine; and the use of anticoagulants

研究者

发起方
Hospital Heliópolis (Brazil)

相似试验

招募中
不适用
Maternal and neonatal effects of remifentanil in women undergoing ceasarean section in relation to multidrug resistance protein 1 (MDR1) and mu-opioid receptor (OPRM) polymorphismspregnant women with hypertension, chronic or gestational, including preeclampsia indicated to caesarean sectionAnaesthesiology - Anaesthetics
ACTRN12612001165875Interni grantove agentury Ministerstva zdravotnictvi (IGA)160
已完成
不适用
Effect of pomegranate extract on carotid atherosclerosisAtherosclerosis, carotid artery diseaseCirculatory SystemAtherosclerosis
ISRCTN30768139POM Wonderful, LLC (USA)200
进行中(未招募)
1 期
Study of two different doses of cabozantinib in progressive, metastatic medullary thyroid cancerProgressive Metastatic Medullary Thyroid CancerMedDRA version: 21.1 Level: PT Classification code 10027105 Term: Medullary thyroid cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2013-003402-40-HUExelixis, Inc.250
进行中(未招募)
1 期
Study of two different doses of cabozantinib in progressive, metastatic medullary thyroid cancerProgressive Metastatic Medullary Thyroid CancerMedDRA version: 21.1Level: PTClassification code 10027105Term: Medullary thyroid cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2013-003402-40-PLExelixis, Inc.250
进行中(未招募)
1 期
Study of two different doses of cabozantinib in progressive, metastatic medullary thyroid cancer
EUCTR2013-003402-40-FRExelixis, Inc.188